Arun SANYAL

Director, Stravitz-Sanyal Institute for Liver Disease & Metabolic Health,Virginia Commonwealth University, Richmond, USA

Arun J. SANYAL, M.D., is a Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. At VCU, he is currently the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. Dr. Sanyal serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE consortium, and the Liver Forum for NASH and fibrosis.

His research interests include all aspects of NAFLD and NASH as well as complications of end-stage liver disease. He has served on numerous advisory boards to pharmaceutical companies and the liver center at Yale University. He chaired the hepatobiliary pathophysiology study section of the NIH and was a founding member of the Hepatology committee of the American Board of Internal Medicine. He has also served as Secretary as well as President of the American Association for the Study of Liver Diseases. Dr. SANYAL has authored more than 350 articles in publications such as Cell Metabolism, Nature Medicine, New England Journal of Medicine, Lancet, Gastroenterology, Hepatology, and the Journal of Infectious Diseases has an H-index of 102. He has been continuously funded by the NIH since 1995 and is the principal investigator of four active NIH grants. He is the recipient of the Distinguished Mentorship Award from the American Gastroenterological Association and the Distinguished Scientific Achievement Award from the American Liver.